Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Emapalumab for Treatment of Impending Graft Failure

Anthony Sabulski, Sonata Jodele, Eleanor Cook, Kasiani Myers, Adam C. Lane, Samppa Ryhanen, Sr., Maria Pia Cefalo, Francesco Quagliarella, Stella M Davies, Ashley Teusink-Cross, Paibel Aguayo-Hiraldo, Jessie L. Alexander, Paul Szabolcs, Mira Kohorst, Tiziana Corsetti, Franco Locatelli, Pietro Merli

Blood (2023) 142 (Supplement 1): 114.

https://doi.org/10.1182/blood-2023-181096

Published: 2023

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes

Jessie L Barnum, Kathryn Torok, Franziska Rosser, Nicole Hogue, Shawna Mcintyre, Haley Havrilla, Vickie Vandergrift, Kirsten Rose-Felker, Vibha Sood, Adam Olson, Paul Szabolcs

Blood (2022) 140 (Supplement 1): 7707–7709.

https://doi.org/10.1182/blood-2022-167533

Published: 2022

Journal Articles

Distinct Patterns in the Reconstitutions of Treg and T-Helper Subsets after Autologous Hematopoietic Stem Cell Transplantation in Juvenile-Onset Systemic Sclerosis Patients

Paul Szabolcs, Evelyn Garchar, Xiaohua Chen, Anwesha Sanyal, Giffin Werner, Jessie L. Barnum, Kathryn Torok

Blood (2022) 140 (Supplement 1): 7701–7702.

https://doi.org/10.1182/blood-2022-167048

Published: 2022

Journal Articles

Gene Expression Profiling and Signaling Pathway Analysis of Tolerant T Cells Circulating in Adult Patients after Ptcy Haplotransplantation

Paul Szabolcs, Taylor Nee, Xiaohua Chen, Dhivyaa Rajasundaram, Rafic J. Farah

Blood (2022) 140 (Supplement 1): 10525–10526.

https://doi.org/10.1182/blood-2022-167472

Published: 2022

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Is Associated with Robust Immune Reconstitution and Lower Rates of Severe Infection Compared to Standard Umbilical Cord Blood Transplantation

Paul Szabolcs, Stuart Levy, Dima Yackoubov, Aviad Pato, Einat Galamidi-Cohen, Mitchell E. Horwitz

Blood (2021) 138 (Supplement 1): 333.

https://doi.org/10.1182/blood-2021-153408

Published: 2021

Journal Articles

Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease

Isabel C. Yoon, Nicholas A. Bascou, Michele D. Poe, Paul Szabolcs, Maria L. Escolar

Blood (2021) 137 (13): 1719–1730.

https://doi.org/10.1182/blood.2020005477

Published: 2021

Includes: Supplemental data

Journal Articles

Safe & Effective Reduced Intensity Conditioning Regimen in Patients with Dyskeratosis Congenita

Archana Ramgopal, DO, Beth Carella, DO, Paul Szabolcs, MD, Steven William Allen, MD BS, Jessie L. Barnum, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-140621

Published: 2020

Journal Articles

Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects

Blood (2019) 133 (18): 1977–1988.

https://doi.org/10.1182/blood-2018-11-886028

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

Mark Vander Lugt, MD, Beth Carella, DO, Heather Stanczak, Xiaohua Chen, MD PhD, Paul Szabolcs, MD

Blood (2018) 132 (Supplement 1): 3414.

https://doi.org/10.1182/blood-2018-99-119261

Published: 2018

Journal Articles

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

Elie Haddad, Brent R. Logan, Linda M. Griffith, Rebecca H. Buckley, Roberta E. Parrott, Susan E. Prockop, Trudy N. Small, Jessica Chaisson, Christopher C. Dvorak, Megan Murnane, Neena Kapoor, Hisham Abdel-Azim, Imelda C. Hanson, Caridad Martinez, Jack J. H. Bleesing, Sharat Chandra, Angela R. Smith, Matthew E. Cavanaugh, Soma Jyonouchi, Kathleen E. Sullivan, Lauri Burroughs, Suzanne Skoda-Smith, Ann E. Haight, Audrey G. Tumlin, Troy C. Quigg, Candace Taylor, Blachy J. Dávila Saldaña, Michael D. Keller, Christine M. Seroogy, Kenneth B. Desantes, Aleksandra Petrovic, Jennifer W. Leiding, David C. Shyr, Hélène Decaluwe, Pierre Teira, Alfred P. Gillio, Alan P. Knutsen, Theodore B. Moore, Morris Kletzel, John A. Craddock, Victor Aquino, Jeffrey H. Davis, Lolie C. Yu, Geoffrey D. E. Cuvelier, Jeffrey J. Bednarski, Frederick D. Goldman, Elizabeth M. Kang, Evan Shereck, Matthew H. Porteus, James A. Connelly, Thomas A. Fleisher, Harry L. Malech, William T. Shearer, Paul Szabolcs, Monica S. Thakar, Mark T. Vander Lugt, Jennifer Heimall, Ziyan Yin, Michael A. Pulsipher, Sung-Yun Pai, Donald B. Kohn, Jennifer M. Puck, Morton J. Cowan, Richard J. O'Reilly, Luigi D. Notarangelo

Blood (2018) 132 (17): 1737–1749.

https://doi.org/10.1182/blood-2018-03-840702

Published: 2018

Includes: Supplemental data

Journal Articles

Enhancing Cytotoxicity of Autologous T Cells in AML By Blockade of CTLA-4 and PD-1

Kirsten Marie Boughan, DO, Xiaohua Chen, MD PhD, Paul Szabolcs, MD

Blood (2016) 128 (22): 4057.

https://doi.org/10.1182/blood.V128.22.4057.4057

Published: 2016

Journal Articles

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Paul Szabolcs, MD, Xiaohua Chen, MD PhD, Mark Vander Lugt, MD, Memphis J Hill, BS

Blood (2016) 128 (22): 4584.

https://doi.org/10.1182/blood.V128.22.4584.4584

Published: 2016

Journal Articles

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Julie R. Boiko, MS, Annie Im, MD, Xiaohua Chen, MDPhD, Memphis J Hill, BS, Paul Szabolcs, MD

Blood (2015) 126 (23): 1932.

https://doi.org/10.1182/blood.V126.23.1932.1932

Published: 2015

Journal Articles

Distinct Pattern of Regulatory T Cell Reconstitution after Umbilical Cord Blood Transplantation in Pediatric Patients with Reduced Intensity Conditioning Regimen

Xiaohua Chen, MDPhD, Mark Vander Lugt, MD, Memphis J Hill, BS, Paul Szabolcs, MD

Blood (2015) 126 (23): 1951.

https://doi.org/10.1182/blood.V126.23.1951.1951

Published: 2015

Journal Articles

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Mark Vander Lugt, MD, Hey Jin Chong, MD PhD, Xiaohua Chen, MDPhD, Randy M. Windreich, MD, Rakesh Goyal, MD MRCP, Maria Escolar, MD, Paul Szabolcs, MD

Blood (2015) 126 (23): 4329.

https://doi.org/10.1182/blood.V126.23.4329.4329

Published: 2015

Journal Articles

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)

Rohtesh S. Mehta, MD MPH, MS, Xiaohua Chen, PhD, Antony Jeyaraj, PhD, Paul Szabolcs, MD

Blood (2014) 124 (21): 5806.

https://doi.org/10.1182/blood.V124.21.5806.5806

Published: 2014

Journal Articles

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Jeyaraj Antony, PhD, Xiaohua Chen, PhD, Paul Szabolcs, MD

Blood (2013) 122 (21): 3266.

https://doi.org/10.1182/blood.V122.21.3266.3266

Published: 2013

Journal Articles

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Ann M. Leen, Catherine M. Bollard, Adam M. Mendizabal, Elizabeth J. Shpall, Paul Szabolcs, Joseph H. Antin, Neena Kapoor, Sung-Yun Pai, Scott D. Rowley, Partow Kebriaei, Bimalangshu R. Dey, Bambi J. Grilley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop

Blood (2013) 121 (26): 5113–5123.

https://doi.org/10.1182/blood-2013-02-486324

Published: 2013

Includes: Supplemental data

Journal Articles

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M. Bollard, MD, Adam M. Mendizabal, MS, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Sung-Yun Pai, MD, Scott D. Rowley, MD, Partow Kebriaei, M.D., Bambi J. Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2012) 120 (21): 457.

https://doi.org/10.1182/blood.V120.21.457.457

Published: 2012

Journal Articles

IL-15 Induced Polyclonal CTL Generated From Expanded CBT Cells Against Leukemia Cell Lines Constitutes IFN-γ Producing Cells and TCRγδ Cells

Jeyaraj Antony, PhD, Xiaohua Chen, PhD, Paul Szabolcs, MD

Blood (2012) 120 (21): 1910.

https://doi.org/10.1182/blood.V120.21.1910.1910

Published: 2012

NARROW

Emapalumab for Treatment of Impending Graft Failure

Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes

Distinct Patterns in the Reconstitutions of Treg and T-Helper Subsets after Autologous Hematopoietic Stem Cell Transplantation in Juvenile-Onset Systemic Sclerosis Patients

Gene Expression Profiling and Signaling Pathway Analysis of Tolerant T Cells Circulating in Adult Patients after Ptcy Haplotransplantation

Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Is Associated with Robust Immune Reconstitution and Lower Rates of Severe Infection Compared to Standard Umbilical Cord Blood Transplantation

Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease

Safe & Effective Reduced Intensity Conditioning Regimen in Patients with Dyskeratosis Congenita

Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

Enhancing Cytotoxicity of Autologous T Cells in AML By Blockade of CTLA-4 and PD-1

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Distinct Pattern of Regulatory T Cell Reconstitution after Umbilical Cord Blood Transplantation in Pediatric Patients with Reduced Intensity Conditioning Regimen

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)

CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

IL-15 Induced Polyclonal CTL Generated From Expanded CBT Cells Against Leukemia Cell Lines Constitutes IFN-γ Producing Cells and TCRγδ Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only